Summary: Researchers have identified a compact, specialized population of neurons in the mouse hypothalamus that directly regulate feeding and body weight. These PNOC/NPY neurons increase food intake when activated and are also present in the human brain. A small subset of these cells carries leptin receptors; removing those receptors causes mice to overeat and gain weight. The finding points to a narrowly focused neural target that may enable more precise anti-obesity therapies.
Although several highly effective anti-obesity medications have been developed in recent years, not all patients respond and some experience side effects. That leaves an ongoing need for alternative approaches. By identifying a specific cluster of hypothalamic neurons that mediates leptin’s appetite-suppressing effects, this research highlights a potential path for safer, more targeted treatments.
Key Facts:
- Obesity connection: A very small subset of PNOC-expressing neurons in the arcuate nucleus of the hypothalamus drives increased food intake and weight gain in mice.
- Leptin sensitivity: About 10% of these PNOC neurons express the leptin receptor. Loss of leptin signaling in this subpopulation leads to overeating and obesity.
- Therapeutic potential: Because the effect is mediated by a narrowly defined neural cluster, it may be possible to design treatments that target these cells specifically, reducing off-target effects.
Source: Max Planck Society
Context: Obesity remains a major global health challenge. While recent pharmacological advances have substantially improved options for many patients, some individuals either do not achieve sufficient benefit or experience intolerable side effects. Identifying the precise neural circuits that control appetite and energy balance is essential for developing alternative therapies with better safety and efficacy profiles.
Scientists at the Max Planck Institute for Metabolism Research used advanced genetic and molecular methods to profile PNOC-expressing neurons at single-cell resolution. That analysis revealed distinct clusters within the broader PNOC population. Functional testing showed that only one of those clusters—characterized by co-expression of neuropeptide Y (NPY)—is responsible for driving the increased feeding and consequent weight gain observed when these neurons are activated.
Single-cell precision reveals a critical cluster
By combining single-cell transcriptomics with targeted manipulation of neuronal activity, the research team demonstrated that selective activation of PNOC/NPY neurons increases food intake to a degree similar to activating the entire PNOC population in the arcuate nucleus. Conversely, altering molecular signaling within this small subgroup had marked effects on energy balance. These results highlight how a narrowly defined cell type within a larger population can exert outsized influence on behavior and metabolism.
Role of leptin signaling
Leptin, a hormone produced by adipose tissue, normally signals satiety to the brain. The investigators found that roughly one in ten PNOC neurons in the arcuate nucleus express the leptin receptor (Lepr). When Lepr was selectively removed from PNOC neurons, mice developed hyperphagia (excessive eating) and gained weight, even without changes to diet composition. Restoring Lepr expression in PNOC neurons on a leptin-receptor–deficient background substantially reduced body weight, confirming that leptin action on this cellular subset is physiologically important.
Loss of leptin receptor signaling in PNOC neurons also increased expression of Npy in a subpopulation of PNOC cells that do not express agouti-related peptide (Agrp), linking leptin responsiveness, NPY signaling, and feeding behavior in this defined circuit.
“It was surprising that such a small group of nerve cells specifically leads to obesity,” says Marie Holm Solheim, the study’s first author. The researchers emphasize that while the results in mice are compelling, further work is required to translate these findings into safe, effective treatments for people.
The team plans to continue dissecting molecular features of the PNOC/NPY cluster to identify potential druggable targets. The goal is to develop pharmacological strategies that modulate this precise neuronal population, which could provide therapeutic benefit while minimizing side effects associated with broader-acting interventions.
“We hope that drugs targeted to this specialized group of neurons will offer promising alternatives,” says Jens Brüning, head of the study. “However, significant research and development remain before such approaches can be applied clinically.”
About this obesity and neuroscience research news
Author: Marie Holm Solheim
Source: Max Planck Society
Contact: Marie Holm Solheim – Max Planck Society
Image: Image credited to Neuroscience News
Original Research: Open access. “Hypothalamic PNOC/NPY neurons constitute mediators of leptin-controlled energy homeostasis” by Marie Holm Solheim et al., Cell.
Abstract
Hypothalamic PNOC/NPY neurons constitute mediators of leptin-controlled energy homeostasis
Leptin acts in the brain to suppress appetite, but the exact neural circuits that mediate leptin’s anorectic effects are not fully defined. Prepronociceptin (PNOC)-expressing neurons have been implicated in diet-induced hyperphagia and weight gain in mice. The present work demonstrates that leptin regulates appetite and body weight in part via PNOC neurons: loss of leptin receptor (Lepr) expression in PNOC-expressing neurons of the arcuate nucleus causes hyperphagia and obesity. Restoring Lepr expression in PNOC neurons on a Lepr-null obese background substantially reduces body weight. Lepr inactivation in PNOC neurons increases neuropeptide Y (Npy) expression in a subset of hypothalamic PNOC neurons that do not express agouti-related peptide (Agrp). Selective chemogenetic activation of PNOC/NPY neurons promotes feeding to the same extent as activating all PNOCARC neurons, and overexpression of Npy in PNOCARC neurons promotes hyperphagia and obesity. These findings identify PNOC/NPYARC neurons as a critical mediator of leptin action and a promising target for obesity therapeutics.